MedWatch

“A backdoor into the life science sector in Israel”

Once again the Ministry of Science, Innovation and Higher Education and the Embassy of Denmark, Tel Aviv invites Danish companies and scientists to experience Israel’s front-edge life science sector.

Foto: Colourbox

One of the world’s leading events in life sciences is held in Israel and is called the IATI BioMed. As a new initiative this year, MEDinIsrael – a conference hosted by the Ministry of Foreign Affairs, Ministry of Industry, Trade & Labor, Ministry of Health and Israel Export Institute – has planned to place their event simultaneously with IATI BioMed 2013. The joint initiatives combined could very well be one of the best opportunities to the life science sector this year.  Israel is known of being a direct life science path into the US.

According to the United States Patent and Trademark Office, Israel has more Medical Device patents per capita than any other country in the world, and ranks 4 in Bio-Pharma Patents per capita. In Europe they rank the second per capita of private biotech companies’ products in pipeline. The life science industry in Israel can be divided in the following sectors: 1) Medical devices, 2) HealthCare IT, 3) Biotechnology, 4) Pharmaceuticals and 5) Life science services.

Lasse Holm Grønning from the Danish Embassy in Tel Aviv (Commercial and Innovation Advisor) explains which market opportunities there are to be found in Israel for companies within the sector.

The Ministry of Science, Innovation and Higher Education and the Embassy has for several years organized a booth at the conference, in which Danish scientists and companies have been represented and received the Embassy’s matchmaking service. This has proven to be very fruitful for enterprises and researchers looking to find collaborators, and for entering the Israeli – and the global – market.

Lasse Holm Grønning, Head of Team Trade and Innovation, Royal Danish Embassy, Tel Aviv, lasgro@um.dk & Niclas Maabari Skovbjerg, intern, Team Trade and Innovation

 Israel gror startups med effektiv inkubationsordning 

 Here is Denmarks benefit of BioMed Israel  

 Bioneer: Vi kan lære meget af israelerne

 Israel is the direct life science path into the US

 Forskerpark i amerikansk biotek-offensiv  

Mere fra MedWatch

Novo Nordisk afsætter yderligere en milliard i fabriksbyggeri

Novo Nordisk udvider sidste års kæmpeinvestering på 17 mia. kr. med yderligere en mia. kr. til opførslen af endnu en fabrik i Kalundborg samt udvidelse af to nuværende produktionsanlæg. Omkring 420 nye stillinger ventes nu som samlet resultat.  

Evaxion sikrer sig mulighed for at rejse 100 mio dollar

Biotekselskabet Evaxion Biotech, der arbejder med udviklingen af vacciner og immunterapi baseret på kunstig intelligens, har sikret sig muligheden for at rejse 100 mio. dollar til finansieringen af selskabets drift i tider med uro på de finansielle markeder. Rettidig omhu, lyder det fra den adm. direktør.

CHMP vil fjerne 100 kopi-midler fra det europæiske marked

Efter svindel med kliniske forsøg hos den indiske CRO Synchron Research Service anbefaler lægemiddelkomiteen CHMP under det europæiske lægemiddelagentur at suspendere markedsføringstilladelser til omkring 100 generiske lægemidler på det europæiske marked.

Ny finansdirektør vil skabe forandring hos WSA

Høreapparatkoncernen WS Audiologys nye finansdirektør, Marianne Wiinholt, er den femte af slagsen siden fusionen i starten af 2019, og kun en måned inde i hendes ansættelse varsler hun store strukturelle ændringer. 

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier